Hepatitis C drugs boost Remdesivir's antiviral activity against COVID-19

(University of Texas at Austin) Drugs used to treat hepatitis C render remdesivir 10 times better at inhibiting the SARS-CoV-2 coronavirus in cell cultures, according to a new study in Cell Reports.